294 related articles for article (PubMed ID: 16329077)
41. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
Li J; Ny A; Leonardsson G; Nandakumar KS; Holmdahl R; Ny T
Am J Pathol; 2005 Mar; 166(3):783-92. PubMed ID: 15743790
[TBL] [Abstract][Full Text] [Related]
42. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids.
Takizawa Y; Suzuki A; Sawada T; Ohsaka M; Inoue T; Yamada R; Yamamoto K
Ann Rheum Dis; 2006 Aug; 65(8):1013-20. PubMed ID: 16449316
[TBL] [Abstract][Full Text] [Related]
43. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
[TBL] [Abstract][Full Text] [Related]
44. Collagen of articular cartilage: the neglected autoantigen of rheumatoid arthritis.
Mackay IR; Rowley MJ
J Rheumatol; 2008 May; 35(5):731-3. PubMed ID: 18464313
[No Abstract] [Full Text] [Related]
45. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
46. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
[TBL] [Abstract][Full Text] [Related]
47. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
Xu Y; Ramsland PA; Davies JM; Scealy M; Nandakumar KS; Holmdahl R; Rowley MJ
Mol Immunol; 2004 Jun; 41(4):411-9. PubMed ID: 15163538
[TBL] [Abstract][Full Text] [Related]
48. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
[TBL] [Abstract][Full Text] [Related]
49. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ
Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562
[TBL] [Abstract][Full Text] [Related]
50. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
51. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.
Li J; Guo Y; Holmdahl R; Ny T
Arthritis Rheum; 2005 Aug; 52(8):2541-8. PubMed ID: 16052596
[TBL] [Abstract][Full Text] [Related]
52. Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis.
Tsuruha J; Masuko-Hongo K; Kato T; Sakata M; Nakamura H; Nishioka K
Arthritis Rheum; 2001 Apr; 44(4):838-45. PubMed ID: 11315923
[TBL] [Abstract][Full Text] [Related]
53. Oxidative modification of type II collagen differentially affects its arthritogenic and tolerogenic capacity in experimental arthritis.
Marcinkiewicz J; Biedroń R; Maresz K; Kwaśny-Krochin B; Bobek M; Kontny E; Maśliński W; Chain B
Arch Immunol Ther Exp (Warsz); 2004; 52(4):284-91. PubMed ID: 15467493
[TBL] [Abstract][Full Text] [Related]
54. The mouse model of collagen-induced arthritis.
Brand DD; Kang AH; Rosloniec EF
Methods Mol Med; 2004; 102():295-312. PubMed ID: 15286392
[TBL] [Abstract][Full Text] [Related]
55. Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro.
Gray RE; Seng N; Mackay IR; Rowley MJ
J Immunol Methods; 2004 Feb; 285(1):55-61. PubMed ID: 14871534
[TBL] [Abstract][Full Text] [Related]
56. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage.
Noyori K; Koshino T; Takagi T; Okamoto R; Jasin HE
J Rheumatol; 1994 Feb; 21(2):293-6. PubMed ID: 8182639
[TBL] [Abstract][Full Text] [Related]
57. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix.
Elsaid KA; Jay GD; Chichester CO
Osteoarthritis Cartilage; 2003 Sep; 11(9):673-80. PubMed ID: 12954238
[TBL] [Abstract][Full Text] [Related]
58. Type II collagen-specific antibodies induce cartilage damage in mice independent of inflammation.
Croxford AM; Whittingham S; McNaughton D; Nandakumar KS; Holmdahl R; Rowley MJ
Arthritis Rheum; 2013 Mar; 65(3):650-9. PubMed ID: 23239042
[TBL] [Abstract][Full Text] [Related]
59. A pH-induced modification of CII increases its arthritogenic properties.
Lundberg K; Ottosson L; Westman E; Sunnerhagen M; Hultenby K; Harris HE
J Autoimmun; 2004 Sep; 23(2):95-102. PubMed ID: 15324928
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
